[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work With Us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Making Pharmaceuticals Show
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Remote Auditing versus On Site Auditing

Remote Auditing versus On Site Auditing

by Charlotte Abbott | Jul 22, 2021 | Audit, Blog

Remote Auditing versus On Site Auditing: For the last 16 months the pharmaceutical world has had to get used to remote auditing as opposed to auditing in person.

Risk Assessments – Evaluating hazards

Risk Assessments – Evaluating hazards

by Charlotte Abbott | Jul 22, 2021 | Blog, Risk Assessments

Risk Assessments: The aim of writing one is to evaluate hazards, then remove that hazard or minimise the level of its risk by adding control measures, as necessary.

WDA(H) & Import – New Guidelines:

WDA(H) & Import – New Guidelines:

by Sally Finlayson | Jul 21, 2021 | Blog, Brexit, GDP/RP, MHRA, RP, Training, WDA(H)

Following Brexit and GB leaving the EU the MHRA have advised that GB wholesale dealers now need to appoint an RPi

API registration

API registration

by Steven Hewison | Jul 21, 2021 | API Registration, Blog

API registration is an MHRA requirement if you manufacture, import or distribute active substances and you are based in the UK.

New Contract RP introduction

New Contract RP introduction

by Steven Hewison | Jul 21, 2021 | Blog, MHRA, RP

New Contract RP says hello! Please allow me to introduce myself as the newest member of PCL’s Contract RP Team.

Export & WDA(H) – Updated Guidelines:

Export & WDA(H) – Updated Guidelines:

by Sally Finlayson | Jul 14, 2021 | Blog, Export Training, MHRA, WDA(H), WDA(H)

As Great Britain (GB) are no longer part of the European Union (EU) since the 1st of January 2021 exit date. It is essential to ensure all the necessary changes have been made to remain MHRA compliant.

« Older Entries
Next Entries »

Recent Posts

  • HPRA Update for Medical Devices
  • Cogent Accredited MHRA Gold Standard Training for Responsible Persons
  • RP Refresher Training

Upcoming Courses

  • RP Forum – tbc on 7 April 2026 10:00 am
  • Introduction to Good Distribution Practice Online Training on 10 April 2026 10:00 am
  • Intro to the Responsible Person (import) Role (Online) on 13 April 2026
  • GDP/RP Cogent Gold Standard Online Training on 14 April 2026
  • Active Pharmaceutical Ingredient (API) and Clinical Trials Online Training on 27 April 2026 2:00 pm

MHRA Alerts & Recalls

Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17
26 March 2026
Class 4 Medicines Defect Notification: Quadrant Pharmaceuticals Limited, Vesomni 6 mg/0.4 mg modified release tablets , EL(26)A/16
26 March 2026
Field Safety Notices: 16 - 20 March 2026
24 March 2026
Class 2 Medicines Recall: Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml, EL(26)A/15
23 March 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow